A case of insulinoma with hypoglycemia that was better managed with lanreotide than octreotide.

Title:: A case of insulinoma with hypoglycemia that was better managed with lanreotide than octreotide.
Document type:: Case Reports
Author(s):: Yamaoka, Keiko; Nagashima, Shuichi; Okada, Nobukazu; Sawayama, Nagisa; Saito, Shinsuke; Takahashi, Manabu; Okada, Kenta; Endo, Kazuhiro; Koizumi, Masaru; Sasanuma, Hideki; Ebihara, Ken; Kasajima, Atsuko; Fukushima, Noriyoshi; Sata, Naohiro; Ishibashi, Shun
Abstract:: Long-acting somatostatin analogs, including lanreotide slow release (LAN-SR) and octreotide long-acting release (OCT-LAR), can improve hypoglycemia in insulinoma. LAN-SR may be more beneficial in some patients with insulinoma than OCT-LAR.
Journal title abbreviation:: Clin Case Rep
Year:: 2021
Journal volume:: 9
Journal issue:: 5
Fulltext / DOI:: doi:10.1002/ccr3.4118
Pubmed ID:: http://view.ncbi.nlm.nih.gov/pubmed/34026158
TUM Institution:: Institut für Allgemeine Pathologie und Pathologische Anatomie
BibTeX

Occurrences: